Safety, Tolerability, and Effect on Opioid Use of Meloxicam IV Following Orthopedic Surgery

OBJECTIVE: A Phase 3 randomized multicenter, double-blind, placebo-controlled trial (NCT02720692) compared once-daily intravenous (IV) meloxicam 30 mg to placebo, when added to the standard of care pain management regimens, in adults with moderate-to-severe pain following major elective surgery and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharpe, Kipling P, Berkowitz, Richard, Tyndall, William A, Boyer, David, McCallum, Stewart W, Mack, Randall J, Du, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982445/
https://www.ncbi.nlm.nih.gov/pubmed/32021411
http://dx.doi.org/10.2147/JPR.S216219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982445/
https://www.ncbi.nlm.nih.gov/pubmed/32021411
http://dx.doi.org/10.2147/JPR.S216219

Ejemplares similares